Form 8-K - Current report:
SEC Accession No. 0000885590-20-000023
Filing Date
2020-04-29
Accepted
2020-04-29 17:02:40
Documents
14
Period of Report
2020-04-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8k42920agmresults.htm   iXBRL 8-K 76584
  Complete submission text file 0000885590-20-000023.txt   225278

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200429.xsd EX-101.SCH 4447
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200429_cal.xml EX-101.CAL 624
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200429_def.xml EX-101.DEF 1474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200429_lab.xml EX-101.LAB 27205
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200429_pre.xml EX-101.PRE 14099
11 EXTRACTED XBRL INSTANCE DOCUMENT a8k42920agmresults_htm.xml XML 4645
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 20831352
SIC: 2834 Pharmaceutical Preparations